The ICN is particularly emphasized the need to see the issue of falsified medicines as ‘a symptom of a larger problem’, namely a lack of access to high-quality, affordable and effective healthcare. The Council is encouraging the Member State Mechanism to engage with our campaign and to foster collaborative action with important stakeholders in the fight against fake medicines.
The introduction and popularity of new, highly-effective weight loss drugs, which has the same active ingredient (semaglutide) as a diabetes medicine, and available by prescription, have created a situation where market demand greatly exceeds product Read more…
We support and amplify the statements delivered by our members World Heart Federation and US Pharmacopeia and other stakeholders such as Médecins Sans Frontières and International Pharmaceutical Federation on agenda item 13.3 Substandard and falsified Read more…
The Fight the Fakes Alliance is pleased to welcome Adesanya Oluwaseun Adedotun as its first Goodwill Ambassador. Adedotun, the Assistant Director of the Drug Division in the Post Market Surveillance DGO at National Agency for Read more…